Transgender patient undergoing Rezum therapy: a case report.

Area of Science:

• Urology
• Endocrinology
• Transgender Healthcare

Background:

• Benign prostatic hyperplasia (BPH) is common in aging men.
• Rezūm therapy, using water vapor to ablate prostate tissue, is an established minimally invasive BPH treatment.
• Limited data exists on Rezūm's use in transgender populations.

Observation:

• A transgender woman diagnosed with benign prostatic hyperplasia presented for treatment.
• The patient received Rezūm therapy, a novel application in this demographic.
• This marks the first documented case of Rezūm utilization in a transgender patient.

Findings:

• Rezūm therapy was successfully employed to treat benign prostatic hyperplasia in a transgender woman.
• The procedure involved ablating prostatic tissue with water vapor.
• This case demonstrates the feasibility of Rezūm for BPH in transgender individuals.

Implications:

• This case expands the understanding of Rezūm therapy's applicability beyond cisgender men.
• It highlights the need for inclusive BPH treatment options for transgender patients.
• Further research is warranted to evaluate Rezūm's long-term efficacy and safety in the transgender community.